0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Extended Release Drug Market Size, Status and Forecast 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Auto-23G2678
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Extended Release Drug Market Size Status and Forecast 2021 2027

Global Extended Release Drug Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-23G2678
Report
July 2021
98 Pages
QYResearch
Region: Global, North America, Europe,
Description
Table of Content
Tables & Figures
Drug delivery systems are engineered technologies for controlled release of drugs or to the targeted delivery of drugs. Drug delivery system is a kind of formulation that enables the administration of therapeutic agents in the body and improves its safety and efficacy by controlling the time, rate and place of drug release in the body. Most of the conventional oral products of drugs are formulated to release the active ingredient as soon as it is administered. Now the pattern has been changed to modified release dosage forms to achieve better therapeutic target. Extended release drugs is a type of dosage forms which allows a two-fold reduction in frequency of dosage administered in the body.
Market Analysis and Insights: Global Extended Release Drug Market
The global Extended Release Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Extended Release Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Extended Release Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Extended Release Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Extended Release Drug market.
Global Extended Release Drug Scope and Market Size
Extended Release Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Extended Release Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Sustained Release Drug
Controlled Release Drug

Segment by Application

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Pfizer
Mallinckrodt
Teva
Johnson & Johnson
Endo Pharmaceuticals
Purdue Pharma
Mylan
Hisamitsu Pharmaceutical
Sun Pharmaceutical Industries
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extended Release Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sustained Release Drug
1.2.3 Controlled Release Drug
1.3 Market by Application
1.3.1 Global Extended Release Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Extended Release Drug Market Perspective (2016-2027)
2.2 Extended Release Drug Growth Trends by Regions
2.2.1 Extended Release Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Extended Release Drug Historic Market Share by Regions (2016-2021)
2.2.3 Extended Release Drug Forecasted Market Size by Regions (2022-2027)
2.3 Extended Release Drug Industry Dynamic
2.3.1 Extended Release Drug Market Trends
2.3.2 Extended Release Drug Market Drivers
2.3.3 Extended Release Drug Market Challenges
2.3.4 Extended Release Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extended Release Drug Players by Revenue
3.1.1 Global Top Extended Release Drug Players by Revenue (2016-2021)
3.1.2 Global Extended Release Drug Revenue Market Share by Players (2016-2021)
3.2 Global Extended Release Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Extended Release Drug Revenue
3.4 Global Extended Release Drug Market Concentration Ratio
3.4.1 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extended Release Drug Revenue in 2020
3.5 Extended Release Drug Key Players Head office and Area Served
3.6 Key Players Extended Release Drug Product Solution and Service
3.7 Date of Enter into Extended Release Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Extended Release Drug Breakdown Data by Type
4.1 Global Extended Release Drug Historic Market Size by Type (2016-2021)
4.2 Global Extended Release Drug Forecasted Market Size by Type (2022-2027)
5 Extended Release Drug Breakdown Data by Application
5.1 Global Extended Release Drug Historic Market Size by Application (2016-2021)
5.2 Global Extended Release Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Extended Release Drug Market Size (2016-2027)
6.2 North America Extended Release Drug Market Size by Type
6.2.1 North America Extended Release Drug Market Size by Type (2016-2021)
6.2.2 North America Extended Release Drug Market Size by Type (2022-2027)
6.2.3 North America Extended Release Drug Market Size by Type (2016-2027)
6.3 North America Extended Release Drug Market Size by Application
6.3.1 North America Extended Release Drug Market Size by Application (2016-2021)
6.3.2 North America Extended Release Drug Market Size by Application (2022-2027)
6.3.3 North America Extended Release Drug Market Size by Application (2016-2027)
6.4 North America Extended Release Drug Market Size by Country
6.4.1 North America Extended Release Drug Market Size by Country (2016-2021)
6.4.2 North America Extended Release Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Extended Release Drug Market Size (2016-2027)
7.2 Europe Extended Release Drug Market Size by Type
7.2.1 Europe Extended Release Drug Market Size by Type (2016-2021)
7.2.2 Europe Extended Release Drug Market Size by Type (2022-2027)
7.2.3 Europe Extended Release Drug Market Size by Type (2016-2027)
7.3 Europe Extended Release Drug Market Size by Application
7.3.1 Europe Extended Release Drug Market Size by Application (2016-2021)
7.3.2 Europe Extended Release Drug Market Size by Application (2022-2027)
7.3.3 Europe Extended Release Drug Market Size by Application (2016-2027)
7.4 Europe Extended Release Drug Market Size by Country
7.4.1 Europe Extended Release Drug Market Size by Country (2016-2021)
7.4.2 Europe Extended Release Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Extended Release Drug Market Size (2016-2027)
8.2 Asia-Pacific Extended Release Drug Market Size by Type
8.2.1 Asia-Pacific Extended Release Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Extended Release Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Extended Release Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Extended Release Drug Market Size by Application
8.3.1 Asia-Pacific Extended Release Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Extended Release Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Extended Release Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Extended Release Drug Market Size by Region
8.4.1 Asia-Pacific Extended Release Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Extended Release Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Extended Release Drug Market Size (2016-2027)
9.2 Latin America Extended Release Drug Market Size by Type
9.2.1 Latin America Extended Release Drug Market Size by Type (2016-2021)
9.2.2 Latin America Extended Release Drug Market Size by Type (2022-2027)
9.2.3 Latin America Extended Release Drug Market Size by Type (2016-2027)
9.3 Latin America Extended Release Drug Market Size by Application
9.3.1 Latin America Extended Release Drug Market Size by Application (2016-2021)
9.3.2 Latin America Extended Release Drug Market Size by Application (2022-2027)
9.3.3 Latin America Extended Release Drug Market Size by Application (2016-2027)
9.4 Latin America Extended Release Drug Market Size by Country
9.4.1 Latin America Extended Release Drug Market Size by Country (2016-2021)
9.4.2 Latin America Extended Release Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extended Release Drug Market Size (2016-2027)
10.2 Middle East & Africa Extended Release Drug Market Size by Type
10.2.1 Middle East & Africa Extended Release Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Extended Release Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Extended Release Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Extended Release Drug Market Size by Application
10.3.1 Middle East & Africa Extended Release Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Extended Release Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Extended Release Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Extended Release Drug Market Size by Country
10.4.1 Middle East & Africa Extended Release Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Extended Release Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Extended Release Drug Introduction
11.1.4 Pfizer Revenue in Extended Release Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Mallinckrodt
11.2.1 Mallinckrodt Company Details
11.2.2 Mallinckrodt Business Overview
11.2.3 Mallinckrodt Extended Release Drug Introduction
11.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2016-2021)
11.2.5 Mallinckrodt Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Extended Release Drug Introduction
11.3.4 Teva Revenue in Extended Release Drug Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Extended Release Drug Introduction
11.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Endo Pharmaceuticals
11.5.1 Endo Pharmaceuticals Company Details
11.5.2 Endo Pharmaceuticals Business Overview
11.5.3 Endo Pharmaceuticals Extended Release Drug Introduction
11.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2016-2021)
11.5.5 Endo Pharmaceuticals Recent Development
11.6 Purdue Pharma
11.6.1 Purdue Pharma Company Details
11.6.2 Purdue Pharma Business Overview
11.6.3 Purdue Pharma Extended Release Drug Introduction
11.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2016-2021)
11.6.5 Purdue Pharma Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Extended Release Drug Introduction
11.7.4 Mylan Revenue in Extended Release Drug Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Hisamitsu Pharmaceutical
11.8.1 Hisamitsu Pharmaceutical Company Details
11.8.2 Hisamitsu Pharmaceutical Business Overview
11.8.3 Hisamitsu Pharmaceutical Extended Release Drug Introduction
11.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2016-2021)
11.8.5 Hisamitsu Pharmaceutical Recent Development
11.9 Sun Pharmaceutical Industries
11.9.1 Sun Pharmaceutical Industries Company Details
11.9.2 Sun Pharmaceutical Industries Business Overview
11.9.3 Sun Pharmaceutical Industries Extended Release Drug Introduction
11.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2016-2021)
11.9.5 Sun Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Extended Release Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Sustained Release Drug
    Table 3. Key Players of Controlled Release Drug
    Table 4. Global Extended Release Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Extended Release Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Extended Release Drug Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Extended Release Drug Market Share by Regions (2016-2021)
    Table 8. Global Extended Release Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Extended Release Drug Market Share by Regions (2022-2027)
    Table 10. Extended Release Drug Market Trends
    Table 11. Extended Release Drug Market Drivers
    Table 12. Extended Release Drug Market Challenges
    Table 13. Extended Release Drug Market Restraints
    Table 14. Global Extended Release Drug Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Extended Release Drug Market Share by Players (2016-2021)
    Table 16. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2020)
    Table 17. Ranking of Global Top Extended Release Drug Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Extended Release Drug Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Extended Release Drug Product Solution and Service
    Table 21. Date of Enter into Extended Release Drug Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Extended Release Drug Revenue Market Share by Type (2016-2021)
    Table 25. Global Extended Release Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Extended Release Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Extended Release Drug Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Extended Release Drug Revenue Market Share by Application (2016-2021)
    Table 29. Global Extended Release Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Extended Release Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Extended Release Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Extended Release Drug Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Extended Release Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Extended Release Drug Market Size by Country (2016-2021) & (US$ Million)
    Table 36. North America Extended Release Drug Market Size by Country (2022-2027) & (US$ Million)
    Table 37. Europe Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Extended Release Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Extended Release Drug Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Extended Release Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Extended Release Drug Market Size by Country (2016-2021) & (US$ Million)
    Table 42. Europe Extended Release Drug Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Extended Release Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Extended Release Drug Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Extended Release Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Extended Release Drug Market Size by Region (2016-2021) & (US$ Million)
    Table 48. Asia-Pacific Extended Release Drug Market Size by Region (2022-2027) & (US$ Million)
    Table 49. Latin America Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Extended Release Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Extended Release Drug Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Extended Release Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Extended Release Drug Market Size by Country (2016-2021) & (US$ Million)
    Table 54. Latin America Extended Release Drug Market Size by Country (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa Extended Release Drug Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Extended Release Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Extended Release Drug Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Extended Release Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Extended Release Drug Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Middle East & Africa Extended Release Drug Market Size by Country (2022-2027) & (US$ Million)
    Table 61. Pfizer Company Details
    Table 62. Pfizer Business Overview
    Table 63. Pfizer Extended Release Drug Product
    Table 64. Pfizer Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
    Table 65. Pfizer Recent Development
    Table 66. Mallinckrodt Company Details
    Table 67. Mallinckrodt Business Overview
    Table 68. Mallinckrodt Extended Release Drug Product
    Table 69. Mallinckrodt Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
    Table 70. Mallinckrodt Recent Development
    Table 71. Teva Company Details
    Table 72. Teva Business Overview
    Table 73. Teva Extended Release Drug Product
    Table 74. Teva Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
    Table 75. Teva Recent Development
    Table 76. Johnson & Johnson Company Details
    Table 77. Johnson & Johnson Business Overview
    Table 78. Johnson & Johnson Extended Release Drug Product
    Table 79. Johnson & Johnson Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
    Table 80. Johnson & Johnson Recent Development
    Table 81. Endo Pharmaceuticals Company Details
    Table 82. Endo Pharmaceuticals Business Overview
    Table 83. Endo Pharmaceuticals Extended Release Drug Product
    Table 84. Endo Pharmaceuticals Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
    Table 85. Endo Pharmaceuticals Recent Development
    Table 86. Purdue Pharma Company Details
    Table 87. Purdue Pharma Business Overview
    Table 88. Purdue Pharma Extended Release Drug Product
    Table 89. Purdue Pharma Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
    Table 90. Purdue Pharma Recent Development
    Table 91. Mylan Company Details
    Table 92. Mylan Business Overview
    Table 93. Mylan Extended Release Drug Product
    Table 94. Mylan Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
    Table 95. Mylan Recent Development
    Table 96. Hisamitsu Pharmaceutical Company Details
    Table 97. Hisamitsu Pharmaceutical Business Overview
    Table 98. Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
    Table 99. Hisamitsu Pharmaceutical Recent Development
    Table 100. Sun Pharmaceutical Industries Company Details
    Table 101. Sun Pharmaceutical Industries Business Overview
    Table 102. Sun Pharmaceutical Industries Extended Release Drug Product
    Table 103. Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2016-2021) & (US$ Million)
    Table 104. Sun Pharmaceutical Industries Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Extended Release Drug Market Share by Type: 2020 VS 2027
    Figure 2. Sustained Release Drug Features
    Figure 3. Controlled Release Drug Features
    Figure 4. Global Extended Release Drug Market Share by Application: 2020 VS 2027
    Figure 5. Hospital Pharmacy Case Studies
    Figure 6. Retail Pharmacy Case Studies
    Figure 7. Online Pharmacy Case Studies
    Figure 8. Extended Release Drug Report Years Considered
    Figure 9. Global Extended Release Drug Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Extended Release Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Extended Release Drug Market Share by Regions: 2020 VS 2027
    Figure 12. Global Extended Release Drug Market Share by Regions (2022-2027)
    Figure 13. Global Extended Release Drug Market Share by Players in 2020
    Figure 14. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Extended Release Drug Revenue in 2020
    Figure 16. Global Extended Release Drug Revenue Market Share by Type (2016-2021)
    Figure 17. Global Extended Release Drug Revenue Market Share by Type (2022-2027)
    Figure 18. North America Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Extended Release Drug Market Share by Type (2016-2027)
    Figure 20. North America Extended Release Drug Market Share by Application (2016-2027)
    Figure 21. North America Extended Release Drug Market Share by Country (2016-2027)
    Figure 22. United States Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Extended Release Drug Market Share by Type (2016-2027)
    Figure 26. Europe Extended Release Drug Market Share by Application (2016-2027)
    Figure 27. Europe Extended Release Drug Market Share by Country (2016-2027)
    Figure 28. Germany Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Extended Release Drug Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Extended Release Drug Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Extended Release Drug Market Share by Region (2016-2027)
    Figure 38. China Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Extended Release Drug Market Share by Type (2016-2027)
    Figure 46. Latin America Extended Release Drug Market Share by Application (2016-2027)
    Figure 47. Latin America Extended Release Drug Market Share by Country (2016-2027)
    Figure 48. Mexico Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Extended Release Drug Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Extended Release Drug Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Extended Release Drug Market Share by Country (2016-2027)
    Figure 54. Turkey Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Extended Release Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Pfizer Revenue Growth Rate in Extended Release Drug Business (2016-2021)
    Figure 58. Mallinckrodt Revenue Growth Rate in Extended Release Drug Business (2016-2021)
    Figure 59. Teva Revenue Growth Rate in Extended Release Drug Business (2016-2021)
    Figure 60. Johnson & Johnson Revenue Growth Rate in Extended Release Drug Business (2016-2021)
    Figure 61. Endo Pharmaceuticals Revenue Growth Rate in Extended Release Drug Business (2016-2021)
    Figure 62. Purdue Pharma Revenue Growth Rate in Extended Release Drug Business (2016-2021)
    Figure 63. Mylan Revenue Growth Rate in Extended Release Drug Business (2016-2021)
    Figure 64. Hisamitsu Pharmaceutical Revenue Growth Rate in Extended Release Drug Business (2016-2021)
    Figure 65. Sun Pharmaceutical Industries Revenue Growth Rate in Extended Release Drug Business (2016-2021)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global and China Polyvinylidene Difluoride Membrane Market Insights Forecast to 2027
Global and China Polyvinylidene Difluoride Membrane Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-0J3512
Thu Sep 23 00:00:00 UTC 2021

Add to Cart

Global and Japan Solid Tumor Drug Market Insights Forecast to 2027
Global and Japan Solid Tumor Drug Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-19N6828
Thu Sep 23 00:00:00 UTC 2021

Add to Cart

Global and United States Industrial Grade Hydrogel Market Insights Forecast to 2027
Global and United States Industrial Grade Hydrogel Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-13B4426
Thu Sep 23 00:00:00 UTC 2021

Add to Cart

Global and United States Phenylethyl Market Insights Forecast to 2027
Global and United States Phenylethyl Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-27F4141
Thu Sep 23 00:00:00 UTC 2021

Add to Cart